And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Thomas Stankovich net worth and biography

Thomas Stankovich Biography and Net Worth

CFO of ReShape Lifesciences

Mr. Stankovich has over 25 years of executive leadership experience as the CFO for multiple public and private healthcare companies. Tom has spent the past nine years as the Global Senior Vice President and CFO of MP Biomedicals, a life sciences and molecular biology-diagnostics company. At MP Biomedicals he was responsible for financial planning and reporting, financial operations and strategy development along with the acquisition and integration of two international companies. Prior to MP Biomedicals, Tom served as CFO at Response Genetics where he successfully led the company through their initial public offering. Additionally, he served as CFO for Cobalis Corporation and for Ribapharm, where he also led the company through their initial public offering, which at the time became the second largest ever IPO in the biotechnology sector. Tom also held CFO positions at ICN International, which later changed names to Valeant Pharmaceuticals.

What is Thomas Stankovich's net worth?: The estimated net worth of Thomas Stankovich is at least $4,084.92 as of October 25th, 2023. Mr. Stankovich owns 22,949 shares of ReShape Lifesciences stock worth more than $4,085 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Stankovich may own. Additionally, Mr. Stankovich receives a salary of $307,120.00 as CFO at ReShape Lifesciences. Learn More about Thomas Stankovich's net worth.
How old is Thomas Stankovich?: Mr. Stankovich is currently 63 years old. There are 3 older executives and no younger executives at ReShape Lifesciences. The oldest executive at ReShape Lifesciences is Dr. Mark B. Knudson Ph.D., Co-Founder and Special Advisor to the CEO, who is 75 years old. Learn More on Thomas Stankovich's age.
What is Thomas Stankovich's salary?: As the CFO of ReShape Lifesciences Inc., Mr. Stankovich earns $307,120.00 per year. There are 3 executives that earn more than Mr. Stankovich. The highest earning executive at ReShape Lifesciences is Mr. Paul F. Hickey, CEO, President & Director, who commands a salary of $506,420.00 per year. Learn More on Thomas Stankovich's salary.
How do I contact Thomas Stankovich?: The corporate mailing address for Mr. Stankovich and other ReShape Lifesciences executives is 1001 Calle Amanecer, San Clemente CA, 92673. ReShape Lifesciences can also be reached via phone at (949) 429-6680 and via email at [email protected]. Learn More on Thomas Stankovich's contact information.
Has Thomas Stankovich been buying or selling shares of ReShape Lifesciences?: Thomas Stankovich has not been actively trading shares of ReShape Lifesciences within the last three months. Most recently, Thomas Stankovich sold 131 shares of the business's stock in a transaction on Wednesday, October 25th. The shares were sold at an average price of $0.27, for a transaction totalling $35.37. Following the completion of the sale, the chief financial officer now directly owns 22,949 shares of the company's stock, valued at $6,196.23. Learn More on Thomas Stankovich's trading history.
Who are ReShape Lifesciences' active insiders?: ReShape Lifesciences' insider roster includes Barton Bandy (CEO), Dan Gladney (Director), and Thomas Stankovich (CFO). Learn More on ReShape Lifesciences' active insiders.
Are insiders buying or selling shares of ReShape Lifesciences?: In the last year, ReShape Lifesciences insiders bought shares 1 times. They purchased a total of 17,702 shares worth more than $26,907.04. In the last year, insiders at the medical device company sold shares 8 times. They sold a total of 735 shares worth more than $1,005.04. The most recent insider tranaction occured on October, 25th when CFO Thomas Stankovich sold 131 shares worth more than $35.37. Insiders at ReShape Lifesciences own 0.1% of the company. Learn More about insider trades at ReShape Lifesciences.
Information on this page was last updated on 10/25/2023.

Thomas Stankovich Insider Trading History at ReShape Lifesciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/25/2023	Sell	131	$0.27	$35.37	22,949
10/11/2023	Sell	39	$0.93	$36.27	23,080
9/1/2023	Sell	118	$0.89	$105.02	23,119
8/24/2023	Sell	39	$1.42	$55.38	23,237
8/4/2023	Sell	108	$1.43	$154.44	23,276
7/6/2023	Sell	106	$1.47	$155.82	23,384
6/30/2023	Buy	17,702	$1.52	$26,907.04	23,490
5/31/2023	Sell	98	$2.41	$236.18	5,788
4/30/2023	Sell	96	$2.36	$226.56	5,886
3/31/2023	Sell	109	$2.60	$283.40	5,982
2/28/2023	Sell	103	$4.25	$437.75	6,091
2/2/2023	Sell	157	$13.29	$2,086.53	6,194
1/24/2023	Sell	158	$7.49	$1,183.42	6,351
11/4/2022	Sell	167	$13.50	$2,254.50	6,655
10/4/2022	Sell	165	$14.00	$2,310.00	6,773
9/6/2022	Sell	96	$19.50	$1,872.00	6,939
8/5/2022	Sell	94	$23.50	$2,209.00	7,035
7/1/2022	Sell	92	$27.50	$2,530.00	7,130
5/31/2022	Buy	400	$46.00	$18,400.00	7,312
4/1/2022	Sell	100	$56.50	$5,650.00	7,003
1/31/2022	Sell	73	$61.00	$4,453.00
1/4/2022	Sell	63	$89.00	$5,607.00
12/2/2021	Sell	86	$91.50	$7,869.00
11/18/2021	Buy	400	$101.00	$40,400.00
11/2/2021	Sell	86	$134.50	$11,567.00
10/1/2021	Sell	73	$138.00	$10,074.00
9/10/2021	Sell	967	$144.50	$139,731.50	6,319
8/30/2021	Buy	300	$171.50	$51,450.00	652
8/20/2021	Buy	300	$161.00	$48,300.00	352

Thomas Stankovich Buying and Selling Activity at ReShape Lifesciences

ReShape Lifesciences Company Overview

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy and ReShape Vest system, a laparoscopically implantable device to enable weight loss and stomach preservation. It also offers ReShapeCare virtual health coaching program, a program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Today's Range

Now: $0.18

$0.17

$0.18

50 Day Range

MA: $0.17

$0.15

$0.19

2 Week Range

Now: $0.18

$0.14

$2.80

Volume

176,064 shs

Average Volume

733,615 shs

Market Capitalization

$2.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

Thomas Stankovich Biography and Net Worth

What is Thomas Stankovich's net worth?

How old is Thomas Stankovich?

What is Thomas Stankovich's salary?

How do I contact Thomas Stankovich?

Has Thomas Stankovich been buying or selling shares of ReShape Lifesciences?

Who are ReShape Lifesciences' active insiders?

Are insiders buying or selling shares of ReShape Lifesciences?